In the present study, we included studies with patients with CRC and the results demonstrated that the SUVmax in patients with mutated-type KRAS was significantly increased compared with those with wild type, suggesting that there is a significant association between the SUVmax and KRAS mutation. The gene discussed is KRAS; the disease is colorectal carcinoma.